Professor of Pathology and Vice-Chair of Research within the Robert J. Tomsich Pathology & Laboratory Medicine Institute within the Cleveland Clinic
World-renowned molecular pathologist and researcher with a successful track record and a focused interest in the diagnosis and treatment of sarcomas
Author of over 100 peer-reviewed journal articles and author of numerous reviews and book chapters on sarcomas
Co- authored the WHO Classification of Tumors of Bone and Soft Tissue Tumors (sarcomas) (2002 and 2012)
Played key roles in the identification of therapeutic targets in gastrointestinal stromal tumor (GIST) and dermatofibrosarcoma protuberans – resulting in FDA approval of imatinib mesylate - Gleevec as first line medical therapy in these diseases
Pitfalls in Diagnostic Pathology: GI, Pulmonary, Endocrine and Soft Tissue
The Classificatoin of Benign Nerve Sheath Tumors (06/23/2016)
Soft Tissue Lesions of Skin and Subcutis (06/23/2016)
Spindle Cell Sarcomas of the Deep Soft Tissues (06/21/2016)
GIST Update (06/20/2016)
Do you want to include a SAMs/MOCs Exam with this course?
No cart item available
Due to COVID-19, Scientific Symposiums International has rescheduled several live 2020 CME courses to 2021, 2022 and 2023. In addition to holding our traditional live courses in Hawaii and San Diego, we are planning to stream them at the same time. However, some of the courses may need to be streamed instead of held live, if there are travel and accommodation restrictions at those locations.
We need your help in developing the format for the stand alone streaming courses to better fit your needs and schedules. Below is a short survey for you to answer. There is also space at the end of the survey for your thoughts regarding our courses.
I understand that the streaming option for this course is a one-time only event and agree that I will use the material
for personal use only, and that I will not post the videos on any platform or hold viewings for groups.